XENE Earnings Xenon Pharmaceuticals Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–44 of 44
| Q2 2026 | 2026-06-30 | -2.28 | 2026-08-06 | 10-Q |
| Q1 2026 | 2026-03-31 | -1.17 | 2026-05-07 | 10-Q |
| FY 2025 | 2025-12-31 | -4.36 | 2026-02-26 | 10-K |
| Q3 2025 | 2025-09-30 | -3.05 | 2025-11-03 | 10-Q |
| Q2 2026 | 2025-06-30 | -1.90 | 2026-08-06 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.83 | 2026-05-07 | 10-Q |
| FY 2025 | 2024-12-31 | -3.01 | 2026-02-26 | 10-K |
| Q3 2025 | 2024-09-30 | -2.17 | 2025-11-03 | 10-Q |
| Q2 2025 | 2024-06-30 | -1.36 | 2025-08-11 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.62 | 2025-05-12 | 10-Q |
| FY 2025 | 2023-12-31 | -2.73 | 2026-02-26 | 10-K |
| Q3 2024 | 2023-09-30 | -2.09 | 2024-11-12 | 10-Q |
| Q2 2024 | 2023-06-30 | -1.36 | 2024-08-08 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.63 | 2024-05-09 | 10-Q |
| FY 2024 | 2022-12-31 | -2.06 | 2025-02-27 | 10-K |
| Q3 2023 | 2022-09-30 | -1.49 | 2023-11-08 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.91 | 2023-08-09 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.35 | 2023-05-09 | 10-Q |
| FY 2023 | 2021-12-31 | -1.77 | 2024-02-29 | 10-K |
| Q3 2022 | 2021-09-30 | -1.29 | 2022-11-08 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.94 | 2022-08-09 | 10-Q |
| FY 2022 | 2020-12-31 | -0.81 | 2023-03-01 | 10-K |
| Q2 2020 | 2020-06-30 | -0.22 | 2020-08-06 | 10-Q |
| Q2 2020 | 2019-06-30 | -0.80 | 2020-08-06 | 10-Q |
| Q1 2019 | 2019-03-31 | -0.42 | 2019-05-07 | 10-Q |
| FY 2018 | 2018-12-31 | -1.63 | 2019-03-06 | 10-K |
| Q3 2018 | 2018-09-30 | -1.34 | 2018-11-06 | 10-Q |
| Q2 2018 | 2018-06-30 | -0.66 | 2018-08-07 | 10-Q |
| Q1 2019 | 2018-03-31 | -0.21 | 2019-05-07 | 10-Q |
| FY 2018 | 2017-12-31 | -1.72 | 2019-03-06 | 10-K |
| Q3 2018 | 2017-09-30 | -1.27 | 2018-11-06 | 10-Q |
| Q2 2018 | 2017-06-30 | -0.84 | 2018-08-07 | 10-Q |
| Q1 2018 | 2017-03-31 | -0.43 | 2018-05-08 | 10-Q |
| FY 2017 | 2016-12-31 | -1.48 | 2018-03-07 | 10-K |
| Q3 2017 | 2016-09-30 | -1.16 | 2017-11-07 | 10-Q |
| Q2 2017 | 2016-06-30 | -0.65 | 2017-08-03 | 10-Q |
| Q1 2017 | 2016-03-31 | -0.23 | 2017-05-09 | 10-Q |
| FY 2017 | 2015-12-31 | -1.10 | 2018-03-07 | 10-K |
| FY 2016 | 2015-09-30 | -0.27 | 2017-03-08 | 10-K |
| FY 2016 | 2015-06-30 | -0.07 | 2017-03-08 | 10-K |
| FY 2016 | 2015-03-31 | -0.64 | 2017-03-08 | 10-K |
| FY 2016 | 2014-12-31 | 3.28 | 2017-03-08 | 10-K |
| FY 2015 | 2014-09-30 | 1.69 | 2016-03-08 | 10-K |
| FY 2015 | 2013-12-31 | 1.91 | 2016-03-08 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.